DK489689D0 - 4-nitrophenyldihydropyridinamider og fysiologisk uskadelige salte deraf, deres anvendelse og mellemprodukter ved deres fremstilling - Google Patents

4-nitrophenyldihydropyridinamider og fysiologisk uskadelige salte deraf, deres anvendelse og mellemprodukter ved deres fremstilling

Info

Publication number
DK489689D0
DK489689D0 DK489689A DK489689A DK489689D0 DK 489689 D0 DK489689 D0 DK 489689D0 DK 489689 A DK489689 A DK 489689A DK 489689 A DK489689 A DK 489689A DK 489689 D0 DK489689 D0 DK 489689D0
Authority
DK
Denmark
Prior art keywords
nitrophenyldihydropyridinamides
intermediates
preparation
salts
physiologically
Prior art date
Application number
DK489689A
Other languages
English (en)
Other versions
DK489689A (da
Inventor
Juergen Stoltefuss
Eckhard Schwenner
Rainer Gross
Siegbert Hebisch
Matthias Schramm
Martin Bechem
Claudia Hirth
Johannes-Peter Stasch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK489689D0 publication Critical patent/DK489689D0/da
Publication of DK489689A publication Critical patent/DK489689A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK489689A 1988-10-05 1989-10-04 4-nitrophenyldihydropyridinamider og fysiologisk uskadelige salte deraf, deres anvendelse og mellemprodukter ved deres fremstilling DK489689A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833893A DE3833893A1 (de) 1988-10-05 1988-10-05 Verwendung von basischen nitro-phenyl-dihydropyridin-amiden als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung ueber neue zwischenprodukte

Publications (2)

Publication Number Publication Date
DK489689D0 true DK489689D0 (da) 1989-10-04
DK489689A DK489689A (da) 1990-04-06

Family

ID=6364450

Family Applications (1)

Application Number Title Priority Date Filing Date
DK489689A DK489689A (da) 1988-10-05 1989-10-04 4-nitrophenyldihydropyridinamider og fysiologisk uskadelige salte deraf, deres anvendelse og mellemprodukter ved deres fremstilling

Country Status (16)

Country Link
US (1) US5051433A (da)
EP (1) EP0362635A1 (da)
JP (1) JPH02169573A (da)
KR (1) KR900006290A (da)
CN (1) CN1041586A (da)
AU (1) AU616057B2 (da)
CA (1) CA2000080A1 (da)
DE (1) DE3833893A1 (da)
DK (1) DK489689A (da)
FI (1) FI894678A (da)
HU (1) HUT52054A (da)
IL (1) IL91864A0 (da)
NO (1) NO893757L (da)
NZ (1) NZ230866A (da)
PT (1) PT91883A (da)
ZA (1) ZA897533B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3833892A1 (de) * 1988-10-05 1990-04-12 Bayer Ag Basische 4-aryl-dhp-amide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5571827A (en) * 1990-03-13 1996-11-05 Sepracor Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
NL9001752A (nl) * 1990-08-02 1992-03-02 Cedona Pharm Bv Nieuwe 1,4-dihydropyridinederivaten.
AU5568300A (en) * 1999-06-23 2001-01-09 Ajinomoto Co., Inc. Novel dihydropyridine derivative
CN108928895A (zh) * 2018-08-13 2018-12-04 浙江迪萧环保科技有限公司 一种邻位双卤代羧酸的双极膜电渗析环化方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
NO854021L (no) * 1984-10-26 1986-04-28 Bayer Ag 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav.
EP0191724A3 (de) * 1985-01-15 1986-12-03 Sandoz Ag 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DK8602336A (da) * 1985-05-21 1986-11-22
JPS62174050A (ja) * 1985-10-21 1987-07-30 Nippon Shoji Kk 3−アミノカルボニル−1,4−ジヒドロピリジン−5−カルボン酸誘導体、その製法および医薬組成物
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPS63208574A (ja) * 1987-02-24 1988-08-30 Sanwa Kagaku Kenkyusho Co Ltd 1,4−ジヒドロピリジン誘導体及びその塩、これらの製法並びに該化合物を有効成分とする循環器系作用薬
DE3833892A1 (de) * 1988-10-05 1990-04-12 Bayer Ag Basische 4-aryl-dhp-amide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
IL91864A0 (en) 1990-06-10
CA2000080A1 (en) 1990-04-05
FI894678A0 (fi) 1989-10-03
CN1041586A (zh) 1990-04-25
AU616057B2 (en) 1991-10-17
NO893757L (no) 1990-04-06
DK489689A (da) 1990-04-06
AU4261189A (en) 1990-04-26
JPH02169573A (ja) 1990-06-29
US5051433A (en) 1991-09-24
NZ230866A (en) 1991-09-25
PT91883A (pt) 1990-04-30
KR900006290A (ko) 1990-05-07
HU895228D0 (en) 1990-01-28
ZA897533B (en) 1990-06-27
DE3833893A1 (de) 1990-04-12
HUT52054A (en) 1990-06-28
NO893757D0 (no) 1989-09-21
EP0362635A1 (de) 1990-04-11
FI894678A (fi) 1990-04-06

Similar Documents

Publication Publication Date Title
DK374389D0 (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK609489D0 (da) Imidazolderivater, deres fremstilling og anvendelse
DK519189D0 (da) Spiro-isoquinolin-pyrrolidin-tetroner eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK0426476T3 (da) Pyrimidinderivater, deres fremstilling og anvendelse
DK461389A (da) Quinolyloxazol-2-oner og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK388989D0 (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289D0 (da) Piperazindioner, deres fremstilling og anvendelse
DK489689A (da) 4-nitrophenyldihydropyridinamider og fysiologisk uskadelige salte deraf, deres anvendelse og mellemprodukter ved deres fremstilling
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK360189A (da) S-adenosyl-methionin-decarboxylase-inhibitorer, deres fremstilling og anvendelse
DK543788A (da) Reninhaemmende dipeptider eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK371289A (da) Sekundaere polyetheraminer, deres fremstilling og anvendelse
DK489889D0 (da) Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler
DK469389A (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
DK641989D0 (da) Bis-arylphosphatestere, deres fremstilling og anvendelse
DK185489D0 (da) Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
DK404386D0 (da) Spergualinbeslaegtede forbindelser eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK10487A (da) 4-aminoaryldihydropyridinlactoner, deres fremstilling og anvendelse i laegemidler
NO900275D0 (no) Benzopyranderivater, deres fremstilling og anvendelse i legemidler.
DK455189A (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse
DK450788D0 (da) Benzothiazinon-oxider, deres fremstilling og anvendelse
NO921390D0 (no) Indolderivater, deres fremstilling og anvendelse
DK497389D0 (da) Indolderivater, deres fremstilling og anvendelse
DK163589A (da) Sakyomycin e og derivater deraf, deres fremstilling og anvendelse
DK82589D0 (da) Piperidinforbindelser, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn